Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism XLRS1 modulators(Retinoschisin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | - | 02 Dec 2022 |